Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Factor IX/factor IXa activating antibodies and antibody derivatives

Factor IX/factor IXa activating antibodies and antibody derivatives

US Patent 7279161 · Granted Oct 9, 2007

Estimated economic value: $150,773,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS2025
Stabilized liquid and lyophilized ADAMTS13 formulations2024
Removal of serine proteases by treatment with finely divided silicon dioxide2024
TFPI inhibitors and methods of use2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2023
Gene therapy of hemophilia B using viral vectors encoding recombinant fix varian2023
Stabilized liquid and lyophilized ADAMTS13 formulations2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Anti-MIF immunohistochemistry2022
Anti-MIF immunohistochemistry2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Method to produce a highly concentrated immunoglobulin preparation for subcutane2022